Pfizer's free cash flow should improve. The drugmaker's lower leverage ratio target gives it greater financial flexibility.

Pfizer (PFE) stock and BioNTech (BNTX) stock in focus as FDA may not renew the authorization for their pediatric COVID shot. Read more here.

Parents in the United States who want to vaccinate their young children against Covid-19 this fall may face a growing set of ...

GSK and CureVac will together receive $740 million, as well as royalties on sales of COVID-19 vaccines in the US ...

Six months into Donald Trump’s second term, his administration is at war with the federal judiciary, evading court orders ...

Pediatrician Deborah Greenhouse writes that South Carolina is at risk because of the U.S. government’s decision to defund almost $500 million in mRNA vaccine research funding.

Shortly after that, the CDC overhauled its vaccine recommendations in COVID, nixing its endorsement of the shots for pregnant women and healthy children. At the time, RFK Jr. said he “couldn’t be more ...

U.S. Health and Human Services Secretary Robert F. Kennedy Jr. announced last week that his department would slash about $500 ...

Glaxosmithkline, which has major operations in Montgomery County, is set to receive a major settlement, writes Anthony O. Goriainoff for the Wall Street ...

HHS Secretary Robert F. Kennedy Jr. has upended COVID vaccine approvals and recommendations, creating uncertainty where ...

Summit Therapeutics, which has consistently been communicating quarterly results through investor calls in the past few years ...

The research, done in mice and in human cells, shows that a protein called STUB1 restrains the immune system’s elite ...